Skip Navigation



Annals of Oncology Advance Access published online on January 10, 2005
Annals of Oncology, doi:10.1093/annonc/mdi088
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/3/352    most recent
mdi088v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Grevelman, E. G.
Right arrow Articles by Breed, W. P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grevelman, E. G.
Right arrow Articles by Breed, W. P. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology
Received June 22, 2004
Accepted October 26, 2004

Review

Prevention of chemotherapy-induced hair loss by scalp cooling

E. G. Grevelman 1 and W. P. M. Breed 2*

1 University of Maastricht, Nassaulaan 11a, 6224 JT Maastricht, The Netherlands
2 Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands

* To whom correspondence should be addressed.
W. P. M. Breed, E-mail: wpmbreed{at}planet.nl


  Abstract

Background: Chemotherapy-induced temporary hair loss is one of the most common and distressing side-effects of cancer therapy. Scalp cooling to reduce this hair loss is a controversial issue for many doctors and nurses. This may be due to inadequate knowledge.

Methods: This review from 53 publications and three personal communications focuses on the efficacy of the treatment, side-effects, possible disadvantages and the controversies in these areas.

Results: Scalp cooling has become an increasingly effective method to prevent hair loss, especially when anthracyclines or taxanes are used. Unfortunately, many studies were small and badly designed and are therefore difficult to compare. There is a considerable variation in the success rates in the various studies. This remains unexplained, but the cooling time, the chemotherapy used and the temperature seem to be influential. Scalp cooling should not be used if chemotherapy is given with a curative intent in patients with generalised haematogenic metastases. The majority of patients tolerate cooling very well.

Conclusion: Scalp cooling is effective but not for all chemotherapy patients. Further psychological, clinical and biophysical research is needed to determine exact indications for cooling and to improve the effect, tolerance, side-effects and the cooling procedure. Multicentre trials should be carried out to gather this information.

Keywords: alopecia; chemotherapy-induced hair loss; cold cap; hair preservation; hypothermia; scalp cooling.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
C. Christodoulou, G. Tsakalos, E. Galani, and D. V. Skarlos
Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention
Ann. Onc., February 1, 2006; 17(2): 350 - 350.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.